The emergence of resistant strains of Acinetobacter baumannii: clinical and infection control implications.
A prospective study was undertaken to determine colonization rates, susceptibility profiles, and outcomes in patients with clinical isolates of Acinetobacter baumannii. Fifty percent of patients became colonized with A. baumannii, and 29% of these patients had clinical and colonizing isolates with discordant susceptibility profiles, without apparent relation to antibiotic use. Barrier infection control measures are necessary to prevent nosocomial transmission.
Dy
M E
ME
Department of Medicine, St Vincent's Hospital and Medical Center, New York City, New York 10011, USA.
Nord
J A
JA
LaBombardi
V J
VJ
Kislak
J W
JW
D000150:Acinetobacter / Q000187:drug effects* / Q000472:pathogenicity; D000151:Acinetobacter Infections / Q000453:epidemiology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000453:epidemiology / Q000517:prevention & control*; D004352:Drug Resistance, Microbial; D005260:Female; D005767:Gastrointestinal Diseases / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009519:New York City / Q000453:epidemiology; D011446:Prospective Studies
D000900:Anti-Bacterial Agents